Cytochrome P450-activated prodrugs

PR Ortiz de Montellano - Future medicinal chemistry, 2013 - Taylor & Francis
A prodrug is a compound that has negligible, or lower, activity against a specified
pharmacological target than one of its major metabolites. Prodrugs can be used to improve …

[BOOK][B] Chemical reagents for protein modification

RL Lundblad - 2004 - taylorfrancis.com
Revised and updated, Chemical Reagents for Protein Modification, Third Edition is an
encyclopedic work describing the many approaches to the site-specific modification of …

Antiplatelet drug interactions

IS Mackenzie, MWH Coughtrie… - Journal of internal …, 2010 - Wiley Online Library
Mackenzie IS, Coughtrie MWH, MacDonald TM, Wei L.(Medicines Monitoring Unit (MEMO);
and Centre for Oncology & Molecular Medicine, Division of Medical Sciences, University of …

Cytochromes P450 catalyze both steps of the major pathway of clopidogrel bioactivation, whereas paraoxonase catalyzes the formation of a minor thiol metabolite …

PM Dansette, J Rosi, G Bertho… - Chemical research in …, 2012 - ACS Publications
The mechanism generally admitted for the bioactivation of the antithrombotic prodrug,
clopidogrel, is its two-step enzymatic conversion into a biologically active thiol metabolite …

Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response

IY Gong, N Crown, CM Suen, UI Schwarz… - European heart …, 2012 - academic.oup.com
Aims It is thought that clopidogrel bioactivation and antiplatelet response are related to
cytochrome P450 2C19 (CYP2C19). However, a recent study challenged this notion by …

Biotransformations leading to toxic metabolites: chemical aspect

AC Macherey, PM Dansette - The practice of medicinal chemistry, 2008 - Elsevier
Publisher Summary As drugs are usually foreign chemicals, history of concern for the
biotransformations of drugs leading to toxic metabolites formation is intrinsically linked to the …

Spectroscopic and molecular docking studies on N, N-di-tert-butoxycarbonyl (Boc)-2-amino pyridine: A potential bioactive agent for lung cancer treatment

RM Asath, R Premkumar, T Mathavan… - Journal of Molecular …, 2017 - Elsevier
Potential energy surface scan was performed and the most stable molecular structure of the
N, N-di-tert-butoxycarbonyl (Boc)-2-amino pyridine (DBAP) molecule was predicted. The …

The redox chemistry of sulfenic acids

AJ McGrath, GE Garrett, L Valgimigli… - Journal of the American …, 2010 - ACS Publications
A persistent triptycenyl sulfenic acid is used as a model for cysteine-derived and other
biologically relevant sulfenic acids in experiments which define their redox chemistry. EPR …

Overcoming clopidogrel resistance: discovery of vicagrel as a highly potent and orally bioavailable antiplatelet agent

J Shan, B Zhang, Y Zhu, B Jiao, W Zheng… - Journal of medicinal …, 2012 - ACS Publications
A series of optically active 2-hydroxytetrahydrothienopyridine derivatives were designed and
synthesized as prodrugs of clopidogrel thiolactone in order to overcome clopidogrel …

Sulfenic acids as reactive intermediates in xenobiotic metabolism

D Mansuy, PM Dansette - Archives of biochemistry and biophysics, 2011 - Elsevier
Sulfenic acid reactive intermediates are formed during the oxidation of cysteine residues of
proteins and play key roles in enzyme catalysis, redox homeostasis and regulation of cell …